10 AI models forecast HYPE for 2026: median base case $91
Thread859 words
Market since$HYPE+6.9%since this pieceHow it played out ↓Ten LLMs given one shared research brief all came out bullish on HYPE, with base cases of $85 to $110, bull targets of $132 to $180 and median new-ATH odds of 65%. All ten flagged perp volume as the key variable.
Key claims
Median year-end base $91, about +24% from $73.55
Base cases ranged from $85 (Qwen3-Max, DeepSeek) to $110 (Gemini 3.1 Pro)
Gemini gave the highest ATH odds at 85%, Mistral the lowest at 35%
10 of the best AI models.
One research brief.
One question: where does $HYPE close 2026?
Opus 4.8, GPT-5.5, Gemini 3.1, Grok 4.3, DeepSeek V4 Pro, Kimi K2.6, Qwen3-Max, Mistral Large, Llama 4 Maverick, GLM-5.2.
All bullish.
Base cases $85 to $110, bulls to $180, and new-ATH odds from 35% to 85%.
Full analysis in thread below! ↓
1/ Each model got one shared, web-grounded research brief: live price, annualized fees, the 97% fee-to-buyback flywheel, the monthly unlock schedule, every catalyst (HIP-3, HyperEVM, USDH, spot ETFs, etc).
From that, each produced the same structured output: bear, base, and bull scenarios with probabilities, an explicit valuation model, an ATH call, and a year-end target.
Ten analysts, one dataset, zero coordination. Here is the spread, lowest target to highest.
2/ Qwen3-Max
- EOY base $85 (+16% vs spot). Range $45 to $135.
- New ATH by year-end: 65% odds, peak near $92.
- Confidence: 80%.
The buyback retires ~14M HYPE a year against only ~3.6M unlocked, a net ~10.4M supply sink. Prices it at 20x sales, then takes a 10% haircut for the $70B FDV overhang.
3/ DeepSeek-V4-Pro
- EOY base $85 (+16% vs spot). Range $48 to $140.
- New ATH by year-end: 65% odds, peak near $94.
- Confidence: 68%.
At 18.5x sales, HYPE sits between Coinbase (7 to 9x) and Solana (25 to 60x). The L1 re-rate from HyperEVM is not priced in. An exchange with L1 optionality bolted on.
4/ Claude Opus 4.8
- EOY base $88 (+20% vs spot). Range $42 to $135.
- New ATH by year-end: 68% odds, peak near $135.
- Confidence: 62%.
Net buybacks outpace contributor unlocks by 7 to 10x, so the float is shrinking in dollar terms. The binding risk is not dilution, it is volume. 20x circulating sales gets you to roughly $85.
5/ Llama 4 Maverick
- EOY base $90 (+22% vs spot). Range $40 to $140.
- New ATH by year-end: 40% odds, peak near $150.
- Confidence: 80%.
The most skeptical valuation of the ten. A pure fee DCF prints only ~$32, but the buyback engine, roughly 59x the next unlock, is what holds the price up. Bullish on the mechanics, honest about the multiple.
6/ Kimi K2.6
- EOY base $90 (+22% vs spot). Range $42 to $160.
- New ATH by year-end: 80% odds, peak near $180.
- Confidence: 72%.
A dividend stock in drag. 97% of fees buy back float, supply contracts roughly 8M HYPE a year, and it trades at 15.4x fees versus Coinbase at 18 to 22x. The dagger is volume stickiness: trade the supply curve, not the narrative.
7/ GPT-5.5
- EOY base $92 (+25% vs spot). Range $48 to $132.
- New ATH by year-end: 70% odds, peak near $140.
- Confidence: 62%.
A fee-backed exchange asset with an L1 call option attached. Buybacks net-absorb roughly 5.6M HYPE through year-end, about 2.5% of supply, even after unlocks. 19.5x sales on a $1.06B run-rate. The ATH bar is low at $76.70, so a modest move clears it.
8/ GLM-5.2
- EOY base $95 (+29% vs spot). Range $45 to $140.
- New ATH by year-end: 60% odds, peak near $115.
- Confidence: 68%.
Three methods, a 22x P/S anchor, a 30%-growth DCF, and buyback vs unlock absorption, all blend to about $97. The absorption ratio runs 4 to 6x. The bear case is real but narrow: it is not unlocks, it is volume. Watch the tape, not the unlock calendar.
9/ Mistral Large
- EOY base $95 (+29% vs spot). Range $38 to $180.
- New ATH by year-end: 35% odds, peak near $180.
- Confidence: 75%.
The widest range of the ten and the lowest ATH odds. Uses a heavier ~300M dilution assumption, which pushes the real story out to a $100B+ FDV by 2027 and leaves 2026 hostage to unlock absorption and volume elasticity. Bull case is a clean DCF, not hopium.
10/ Grok 4.3
- EOY base $98 (+33% vs spot). Range $42 to $165.
- New ATH by year-end: 55% odds, peak near $145.
- Confidence: 72%.
25x forward revenue on a $1.19B run-rate, the midpoint between today's 18.5x and CEX comps at 30 to 35x, gets to about $114. Buybacks absorb roughly 3.3% of supply. The catalyst that matters: $300B+ monthly volume for three straight months.
11/ Gemini 3.1 Pro
- EOY base $110 (+50% vs spot). Range $50 to $160.
- New ATH by year-end: 85% odds, peak near $160 (highest conviction of the ten).
- Confidence: 80%.
Net +$740M a year of structural flow retires supply faster than vesting releases it, over-absorbing insiders by 3.5x. The whole call is a re-rate from a DEX multiple to a top-3 L1 multiple at 28x sales, with the current ATH only ~4% away.
12/ 10 models, 10 valuation approaches, one direction: up.
- Median year-end base: $91, about +24% from $73.55.
- Base cases ran $85 to $110 (every single one above spot).
- Median new-ATH odds: 65%. Bull targets ran $132 to $180.
The one key variable all ten flagged: perp volume. The flywheel is only as strong as the tape.
Not financial advice.
Hyperliquid.
11 more images on X
How the covered assets moved · since 17 Jun 2026
Prices as of 23 Oct 2026This data piece reports the numbers without making a call on the token, so price moves since publication are shown as market context.
Covered in this piece
Since then
Zero has written 13 more pieces on Hyperliquid and $HYPE since this one.
- State of Hyperliquid: two years after the airdrop (A1 Research report)Covers $HYPE
- Hyperliquid onshore: Payward and Bitnomial's permissioned HIP-3* venueBullish call on $HYPE
- Hyperliquid's US regulatory path: HyperCore, HIP-3 deployers and buildersOn Hyperliquid
- Hyperliquid ecosystem briefing: 14 days of regulation, HIP-3/4, RWAs, revenueBullish call on $HYPE
Daily closes in USD from DefiLlama and Yahoo Finance. Only a bullish or bearish thesis is read as a call; explainers, maps and mentions are context. Not financial advice.